CIK 0001677077 · <br>Emerging growth company
Alzamend Neuro, Inc.
Sign in to watch- Ticker
- ALZN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Apr 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811822909
- Phone
- 844-722-6333
- Business address
- 480 PEACHTREE ROAD NE, SECOND FLOOR, SUITE 103, ATLANTA, GA, 30326
- 5 Insider Annual Insider Trading Report
- 8-K Event Material agreement · Delisting notice · Unregistered share sale · Bylaws or fiscal year change
- 10-K Report Annual Report
- 8-K Event Other events
- 8-K Event Shareholder vote results
- 4 Open-market buy Director bought 108,388 shares at $1.00 ($108,897)
- 8-K Event Delisting notice
- 10-Q Report Quarterly Report
- 424B5 Offering Prospectus
- 8-K Event Material agreement
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Open-market sale Director sold 1,851 shares at $2.07 ($3,825)
- 4 Open-market sale Director sold 3,333 shares at $2.12 ($7,059)
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 4 Open-market sale Director sold 30 shares at $2.29 ($69)
- 8-K Event Bylaws or fiscal year change
- 4 Open-market sale Director sold 121,791 shares at an average $2.42 ($294,548)
Page 2 of 20 · 398 filings